WGWei-Yi Gong

Wei-Yi Gong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wei-Yi Gong has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Icariin Alleviates Bleomycin‐Induced Idiopathic Pulmonary Fibrosis in Mice by Modulating the Gut–Lung Axis and Serum Metabolism

    by Ting Zhang, Weiyi Gong, Cheng Huang, Hongkai Wang, Baojun Liu

    Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of uncertain etiology with few specific and effective therapeutic agents approved for its treatment. We examined the underlying processes and the impact of icariin (ICA) on a bleomycin‐induced pulmonary fibrosis model. After giving ICA orally to the experimental mouse model for 4 weeks, the impact of the drug on pulmonary fibrosis was assessed by immunohistochemical analysis, Masson’s trichrome staining, and hematoxylin and eosin staining. 16S rRNA sequencing and 5R 16S rRNA sequencing were applied to investigate the compositions of the gut and lung microbiota, respectively. The alterations of serum metabolites were assessed using untargeted metabolomic technique. ICA treatment attenuated pulmonary fibrosis in the BLM‐induced mouse model. Meanwhile, ICA regulated the abundance and composition of pulmonary along with intestinal microbiota, especially Akkermansia and Lactobacillus . The strong connections between the intestinal and pulmonary microbiota supported the gut–lung axis. In addition, serum metabolic profiles and related metabolic pathways were influenced by ICA intervention. Spearman’s correlation analysis revealed that Akkermansia or Lactobacillus was significantly associated with various metabolites via corresponding metabolic pathways. ICA has a pulmonary‐protective effect against BLM‐induced pulmonary fibrosis, which appears to modulate serum metabolic profiles by affecting the Akkermansia- or Lactobacillus- involved gut–lung axis.

    • 1 April 2019
      • Vol. 39  (2) , 267-274

    Kidney-Qi deficiency diagnosed by Deng's diagnosis standard was not correlated with aging based on clinical observation of 90 participants

    by Zhengxiao Zhao Zhengxiao, Lumei Liu Lumei, Zihui Tang Zihui, Mohammadtursun Nabijan, Linwei Lu Linwei, Mihui Li Mihui, Yibao Lu Yibao, Shuming Mo Shuming, Wenjuan Ma Wenjuan, Meng Wang Meng, et al.

    OBJECTIVE: To verify the Traditional Chinese Medicine (TCM) theory that kidney-Qi deficiency (KQD) is considered to be the main cause of aging using cross-sectional study. METHODS: Demographic and lifestyle characteris-tics of 90 healthy participants were collected with a self-administered questionnaire. KQD syndrome was diagnosed according to Deng's diagnosis standard. Creatinine-adjusted urinary 8-hydroxy-2'-de-oxyguanosine (8-OH-dG) and 8-isomeric-prostaglandin2a (8-iso-PGF2 alpha), salivary advanced oxidation protein products (AOPPs), malondialdehyde (MDA) and dehydroepiandrosterone-sulfate (DHEA-S) were selected as aging markers and measured using enzyme-linked immunosorbent assay. RESULTS: No significant differences were observed in participant characteristics between the KQD group and non-KQD (NKQD) group (P > 0.05). Levels of 8-OH-dG, 8-iso-PGF2a, AOPPs, and MDA increased with age, except for a slight decrease in 8-OH-dG in the older group. The increase in 8-iso-PGF2 alpha was significant (P < 0.05). DHEA-S significantly decreased with increasing age (P < 0.01). 8-OH-dG levels were higher in the KQD group compared with the NKQD group. Levels of urinary 8-iso-PGF2 alpha, salivary AOPPs, and MDA in the KQD group were lower than in the NKQD group. Salivary DHEA-S was higher in the KQD group compared with the NKQD group. However, differences between KQD group and NKQD group were not significant. CONCLUSION: The current results suggested that KQD syndrome, as diagnosed by Deng's standard, does not underlie the aging phenotype. (C) 2019 JTCM. All rights reserved.

  • Open Access

    Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling

    by Fei Xu, Wen-Qiang Cui, Ying Wei, Jie Cui, Jian Qiu, Ling-Li Hu, Wei-Yi Gong, Jing-Cheng Dong, Bao-Jun Liu

    Background: Accumulating evidence suggests that M2-polarized tumor-associated macrophages (TAMs) play an important role in cancer progression and metastasis, making M2 polarization of TAMs an ever more appealing target for therapeutic intervention. Astragaloside IV (AS-IV), a saponin component isolated from Astragali radix, has been reported to inhibit the invasion and metastasis of lung cancer, but its effects on TAMs during lung cancer progression have not been investigated. Methods: Human THP-1 monocytes were induced to differentiate into M2 macrophages through treatments with IL-4, IL-13, and phorbol myristate acetate (PMA). We used the lung cancer cell lines A549 and H1299 cultured in conditioned medium from M2 macrophages (M2-CM) to investigate the effects of AS-IV on tumor growth, invasion, migration, and angiogenesis of lung cancer cells. Macrophage subset distribution, M1 and M2 macrophage-associated markers, and mRNA expression were analyzed by flow cytometry and quantitative PCR. The activation of adenosine monophosphate-activated protein kinase (AMPK) signaling pathways that mediate M2-CM–promoted tumor migration was detected using western blotting. Results: Here we found that AS-IV significantly inhibited IL-13 and IL-4–induced M2 polarization of macrophages, as illustrated by reduced expression of CD206 and M2-associated genes, and that AS-IV suppressed the M2-CM–induced invasion, migration, and angiogenesis of A549 and H1299 cells. In vivo experiments demonstrated that AS-IV greatly inhibited tumor growth and reduced the number of metastases of Lewis lung cancer. The percentage of M2 macrophages was decreased in tumor tissue after AS-IV treatment. Furthermore, AS-IV inhibited AMPKα activation in M2 macrophages, and silencing of AMPKα partially abrogated the inhibitory effect of AS-IV. Conclusions: AS-IV reduced the growth, invasion, migration, and angiogenesis of lung cancer by blocking the M2 polarization of macrophages partially through the AMPK signaling pathway, which appears to play an important role in AS-IV’s ability to inhibit the metastasis of lung cancer.


  • Open Access

    Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis

    by Zheng-Xiao Zhao, Lin-Wei Lu, Jian Qiu, Qiu-Ping Li, Fei Xu, Bao-Jun Liu, Jing-Cheng Dong, Wei-Yi Gong

    Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis